Germ cell tumors represent 11% of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50% of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.
Casadei C., Schepisi G., Menna C., Chovanec M., Gurioli G., Galla V., et al. (2019). Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management. FUTURE ONCOLOGY, 15(12), 1347-1352 [10.2217/fon-2018-0850].
Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management
Casadei C.;Menna C.;Gurioli G.;Altavilla A.;Marcellini M.;Lolli C.;De Giorgi U.
2019
Abstract
Germ cell tumors represent 11% of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50% of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
